Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
August 5, 2006
Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells"
Santiago Zelenay, Jocelyne Demengeot
Cell Stress
|
September 19, 2022
COX-2 upregulation by tumour cells post-chemotherapy fuels the immune evasive dark side of cancer inflammation
Charlotte R Bell, Santiago Zelenay
Trends in Immunology
|
April 24, 2013
Adaptive immunity after cell death
Santiago Zelenay, Caetano Reis e Sousa
European Journal of Immunology
|
May 6, 2003
Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides
Santiago Zelenay, Fernanda Elías, Juan Fló
Oncoimmunology
|
July 29, 2016
Reducing prostaglandin E2 production to raise cancer immunogenicity
Santiago Zelenay, Caetano Reis e Sousa
The Journal of Experimental Medicine
|
December 22, 2017
Resolving the dark side of therapy-driven cancer cell death
Eduardo Bonavita, Victoria S Pelly, Santiago Zelenay
International Immunology
|
November 4, 2006
Heme oxygenase-1 is not required for mouse regulatory T cell development and function
Santiago Zelenay, Angelo Chora, Miguel P Soares, et al.
European Journal of Immunology
|
December 7, 2023
Prostaglandin E₂ impacts multiple stages of the natural killer cell antitumor immune response
Chloe Patterson, Khodor S Hazime, Santiago Zelenay, et al.
Springer Seminars in Immunopathology
|
July 29, 2006
Regulatory T cells in microbial infection
Jocelyne Demengeot, Santiago Zelenay, Maria Francisca Moraes-Fontes, et al.
Journal of Autoimmunity
|
October 31, 2007
Physiopathology of natural auto-antibodies: the case for regulation
Santiago Zelenay, Maria F Moraes Fontes, Constantin Fesel, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Journal of Immunology (Baltimore, Md. : 1950)
|
August 5, 2006
Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells"
Santiago Zelenay, Jocelyne Demengeot
Cell Stress
|
September 19, 2022
COX-2 upregulation by tumour cells post-chemotherapy fuels the immune evasive dark side of cancer inflammation
Charlotte R Bell, Santiago Zelenay
Trends in Immunology
|
April 24, 2013
Adaptive immunity after cell death
Santiago Zelenay, Caetano Reis e Sousa
European Journal of Immunology
|
May 6, 2003
Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides
Santiago Zelenay, Fernanda Elías, Juan Fló
Oncoimmunology
|
July 29, 2016
Reducing prostaglandin E2 production to raise cancer immunogenicity
Santiago Zelenay, Caetano Reis e Sousa
The Journal of Experimental Medicine
|
December 22, 2017
Resolving the dark side of therapy-driven cancer cell death
Eduardo Bonavita, Victoria S Pelly, Santiago Zelenay
International Immunology
|
November 4, 2006
Heme oxygenase-1 is not required for mouse regulatory T cell development and function
Santiago Zelenay, Angelo Chora, Miguel P Soares, et al.
European Journal of Immunology
|
December 7, 2023
Prostaglandin E₂ impacts multiple stages of the natural killer cell antitumor immune response
Chloe Patterson, Khodor S Hazime, Santiago Zelenay, et al.
Springer Seminars in Immunopathology
|
July 29, 2006
Regulatory T cells in microbial infection
Jocelyne Demengeot, Santiago Zelenay, Maria Francisca Moraes-Fontes, et al.
Journal of Autoimmunity
|
October 31, 2007
Physiopathology of natural auto-antibodies: the case for regulation
Santiago Zelenay, Maria F Moraes Fontes, Constantin Fesel, et al.
Page
of 5